title: The blockade of NMDA receptor ion channels by ketamine is enhanced in developing rat cortical neurons.
abstract: Ketamine is a non-competitive antagonist of NMDA receptors (NMDARs) commonly used as a dissociative anesthetic in many pediatric procedures. Ketamine acts primarily by blocking NMDA ligand-gated channels. Experimental studies indicate that ketamine administration used for inducing clinically relevant anesthesia can lead to neurotoxic effects, such as apoptosis, selectively on immature brain neurons. However, the underlying mechanisms remain unclear. This study used whole-cell patch-clamp recordings in an in vitro preparation of forebrain slices to analyze pharmacologically the differences in the effects of ketamine administration on the NMDAR channel activity between immature and mature neurons. NMDAR channel activity was recorded in the form of evoked NMDAR-mediated excitatory postsynaptic currents (eEPSCs) from the forebrain of both neonatal and adult rats. Results show that ketamine inhibited eEPSCs in a dose-dependent manner in both immature and mature neurons. However, at each concentration of ketamine applied to the brain slice, a more extensive inhibition could be seen in neonatal neurons than in adult neurons. Further, the blocking effect of ketamine on eEPSCs was measured during the period of 1, 3, and 6h after ketamine washout. Inhibition of eEPSCs in immature neurons was still evident 6h after washout. In contrast, the blockade of eEPSCs in mature neurons recovered completely from the inhibition by ketamine in a time-dependent manner. These results indicate that ketamine produces a greater and longer blocking effect on NMDAR channels in immature neurons than in mature neurons. This differential effect is likely to be a critical link to the higher vulnerability to ketamine-induced neurotoxicity in neurons of the developing brain.
authors: Institute for Biomedical Sciences of Pain, Capital Medical University, Beijing, China.
authors: Jianhui
authors: J
authors: Jin
authors: Kerui
authors: K
authors: Gong
authors: Xiaoju
authors: X
authors: Zou
authors: Ruirui
authors: R
authors: Wang
authors: Qing
authors: Q
authors: Lin
authors: Jun
authors: J
authors: Chen
mesh_terms: D000778:Anesthetics, Dissociative / Q000009:adverse effects*; D000818:Animals; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects; D005260:Female; D066298:In Vitro Techniques; D007649:Ketamine / Q000009:adverse effects*; D008297:Male; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D018408:Patch-Clamp Techniques; D016548:Prosencephalon / Q000166:cytology / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*
chemical_list: D000778:Anesthetics, Dissociative; D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine
references: Korean J Physiol Pharmacol. 2009 Jun;13(3):209-14
references: 19885039
references: J Physiol. 2005 Mar 1;563(Pt 2):345-58
references: 15649985
references: Neuroscience. 2010 Mar 31;166(3):852-63
references: 20080153
references: Neurosci Bull. 2010 Jun;26(3):175-87
references: 20502495
references: Neuroscience. 2010 Dec 29;171(4):1314-25
references: 20951771
references: Science. 1993 Apr 2;260(5104):95-7
references: 8096653
references: Brain Res Dev Brain Res. 2001 Jan 31;126(1):81-9
references: 11172889
references: Neurotoxicol Teratol. 2011 Mar-Apr;33(2):220-30
references: 21241795
references: Brain Res Brain Res Rev. 1990 Jan-Apr;15(1):41-70
references: 2163714
references: Toxicol Sci. 2009 Mar;108(1):149-58
references: 19126600
references: Nature. 1994 Mar 24;368(6469):335-9
references: 7907398
references: J Neurosci. 1999 May 15;19(10):4180-8
references: 10234045
references: Curr Opin Pharmacol. 2007 Feb;7(1):39-47
references: 17088105
references: Cereb Cortex. 2005 Mar;15(3):349-58
references: 15269112
references: J Biol Chem. 2011 Mar 4;286(9):7558-66
references: 21190942
references: Nature. 1994 Mar 10;368(6467):144-7
references: 8139656
references: Clin Perinatol. 2009 Jun;36(2):215-26, vii
references: 19559316
references: Anesthesiology. 2010 Jul;113(1):147-59
references: 20526188
references: J Neurosci. 2003 Jul 30;23(17):6876-83
references: 12890782
references: Int J Dev Neurosci. 2009 Nov;27(7):727-31
references: 19580862
references: Anesth Analg. 1998 Nov;87(5):1186-93
references: 9806706
references: J Neurosci. 2010 Feb 17;30(7):2676-85
references: 20164351
references: Curr Opin Neurobiol. 2001 Jun;11(3):327-35
references: 11399431
references: Neuropharmacology. 2008 Dec;55(7):1081-94
references: 18755202
references: Anesth Analg. 2011 Nov;113(5):1161-9
references: 21788311
references: Brain Res Mol Brain Res. 2000 May 31;78(1-2):196-200
references: 10891601
references: Neuron. 1993 Feb;10(2):267-78
references: 8439412
references: Toxicol Sci. 2004 Oct;81(2):364-70
references: 15254342
references: Brain Dev. 2009 Aug;31(7):488-92
references: 19307071
references: Pediatr Res. 2010 Feb;67(2):117-27
references: 20091937
references: Mol Brain. 2009 May 16;2:11
references: 19445686
references: J Neurophysiol. 1993 Nov;70(5):1841-52
references: 7507519
references: Curr Neuropharmacol. 2011 Mar;9(1):256-61
references: 21886601
references: Nature. 2011 Jun 15;475(7354):91-5
references: 21677641
references: J Neurosci. 2005 Jun 29;25(26):6037-46
references: 15987933
references: Neurosci Bull. 2009 Oct;25(5):309-18
references: 19784087
references: Science. 1999 Jan 1;283(5398):70-4
references: 9872743